Montreal

Quebec City Mayor Régis Labeaume announces prostate cancer diagnosis

Best wishes and messages of support are pouring in for Régis Labeaume. His office said he is making his diagnosis public in the spirit of transparency and to raise awareness about screening for men.

Labeaume, mayor for over a decade, goes public to raise awareness about screening for men

Quebec City Mayor Régis Labeaume has announced he has prostate cancer. (Jacques Boissinot/The Canadian Press)

Quebec City Mayor Régis Labeaume has prostate cancer, his office announced today.

A statement from the mayor's office said Labeaume is making his diagnosis public in the spirit of transparency and to raise awareness about screening for men.

Labeaume will stay in his position for now, but the statement said he will gradually reduce his workload and intends to eventually step down for an undetermined period.

Quebec politicians showed their support for the mayor after his diagnosis was announced.

Premier François Legault said he knows Labeaume is a "fighter" and said he looks forward to seeing him come out of this even stronger. 

"We look forward to seeing you in fine form," he said.

Montreal Mayor Valérie Plante wished Labeaume courage on Twitter, saying he has the support of her administration.

Former Montreal mayor Denis Coderre also shared his support on Twitter, saying Labeaume's will is stronger than the disease.

"You can count on me, my brother," Coderre wrote. 

Labeaume was first elected as mayor of Quebec City in 2007.

Comments

To encourage thoughtful and respectful conversations, first and last names will appear with each submission to CBC/Radio-Canada's online communities (except in children and youth-oriented communities). Pseudonyms will no longer be permitted.

By submitting a comment, you accept that CBC has the right to reproduce and publish that comment in whole or in part, in any manner CBC chooses. Please note that CBC does not endorse the opinions expressed in comments. Comments on this story are moderated according to our Submission Guidelines. Comments are welcome while open. We reserve the right to close comments at any time.